Beam Therapeutics Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Beam Therapeutics Inc. has filed 507 SEC EDGAR filings since 09 Aug 2018

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 201-225 of 507 matching filings.

Per page

Current page

144 File 001-39208

144 filing

Filing date: 04 Apr 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-39208

144 filing

Filing date: 04 Apr 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-39208

144 filing

Filing date: 04 Apr 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Apr 2024
Reporting date: 01 Apr 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Apr 2024
Reporting date: 01 Apr 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Apr 2024
Reporting date: 01 Apr 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Apr 2024
Reporting date: 01 Apr 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Apr 2024
Reporting date: 01 Apr 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-39208

144 filing

Filing date: 02 Apr 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 02 Apr 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 02 Apr 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 02 Apr 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 02 Apr 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 01 Apr 2024
Reporting date: 28 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-39208

144 filing

Filing date: 28 Mar 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3ASR File 333-277427

S-3ASR

Filing date: 28 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-277382

S-8

Filing date: 27 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-39208

10-K

Filing date: 27 Feb 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39208

8-K

Filing date: 27 Feb 2024
Reporting date: 27 Feb 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 15 Feb 2024
Reporting date: 13 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91369

ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#2)

Filing date: 14 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91369

SCHEDULE 13G/A

Filing date: 13 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91369

SC 13G/A filing

Filing date: 12 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91369

SC 13G/A filing

Filing date: 09 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91369

SC 13G/A

Filing date: 06 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing